This chapter presents the results of the author’s previously unpublished study of 39 therapy-resistant pemphigus patients who then received rituximab treatment in Razi Hospital, Tehran, Iran, from 2008 to 2012. The maximum time interval between the last dosage of rituximab and follow-up was 1 month.
CITATION STYLE
Mohammad Beigi, P. K. (2018). Research Results. In A Clinician’s Guide to Pemphigus Vulgaris (pp. 93–97). Springer International Publishing. https://doi.org/10.1007/978-3-319-67759-0_20
Mendeley helps you to discover research relevant for your work.